Clinical Trials advanced
Clinical Trial Phase 1 Study 32
A Phase 1 clinical trial investigating peptide drug safety, dosing, and pharmacokinetics in a small group of participants.
By Encyclopeptide Editorial | 1 min read
clinical-trial phase-1 study-32
Overview
A Phase 1 clinical trial investigating peptide drug safety, dosing, and pharmacokinetics in a small group of participants.
Properties
| Property | Value |
|---|---|
| Name | Clinical Trial Phase 1 Study 32 |
| Category | Clinical Trials |
Significance
This molecule plays important roles in biological systems and has potential therapeutic applications.
References
- Encyclopeptide Database. “clinical-trial-phase1-32” monograph. encyclopeptide.com.
Chemical Identity
| Property | Value |
|---|---|
| Name | Clinical Trial Phase 1 Study 32 |
| Category | Clinical Trials |
Test Your Knowledge
Reinforce what you learned about Clinical Trial Phase 1 Study 32 with interactive quizzes on Wikipept.
Take a Quiz on Wikipept